Phase I dose-escalation study of IBI351 (GFH925) monotherapy in patients with advanced solid tumors.

被引：0
|
作者：
Zhou, Qing
Yang, Nong
Zhao, Jun
Dong, Xiaorong
Wang, Huijuan
Yuan, Ying
Yu, Yan
Zhang, Meijiang
Zhang, Sujie
Huang, Mengna
Shen, Yuping
Wu, Yi-Long
机构：
[1] Guangdong Lung Canc Inst, Guangzhou, Peoples R China
[2] Hunan Canc Hosp, Changsha, Peoples R China
[3] Beijing Canc Hosp, Beijing, Peoples R China
[4] Huazhong Univ Sci & Technol, Union Hosp, Tongi Med Coll, Wuhan, Peoples R China
[5] Henan Canc Hosp, Zhengzhou, Peoples R China
[6] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Hangzhou, Zhejiang, Peoples R China
[7] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China
[8] Innovent Biol Inc, Suzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3110
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors
    Yamada, Kazuhiko
    Yamamoto, Noboru
    Yamada, Yasuhide
    Nokihara, Hiroshi
    Fujiwara, Yutaka
    Hirata, Taizo
    Koizumi, Fumiaki
    Nishio, Kazuto
    Koyama, Noriyuki
    Tamura, Tomohide
    CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2528 - 2537
  • [42] A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors
    Leong, Stephen
    Moss, Rebecca A.
    Bowles, Daniel W.
    Ware, Joseph A.
    Zhou, Jing
    Spoerke, Jill M.
    Lackner, Mark R.
    Shankar, Geetha
    Schutzman, Jennifer L.
    van der Noll, Ruud
    Voest, Emile E.
    Schellens, Jan H. M.
    ONCOLOGIST, 2017, 22 (12): : 1491 - 1499
  • [43] Phase I, dose-escalation study of the investigational drug TAK-733, an oral MEK inhibitor, in patients (pts) with advanced solid tumors.
    Adjei, Alex A.
    LoRusso, Patricia
    Ribas, Antoni
    Sosman, Jeffrey Alan
    Pavlick, Anna C.
    Dy, Grace K.
    Zhou, Xiaofei
    Gangolli, Esha A.
    Walker, Russell M.
    Kneissl, Michelle
    Faucette, Stephanie
    Neuwirth, Rachel
    Bozon, Viviana
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Phase I dose-escalation study of ON 01910. Na in combination with oxaliplatin in patients with advanced solid tumors
    Chaudhary, I.
    Rajdev, L.
    Swami, U.
    Wilhelm, F.
    Cohen, B.
    Haigentz, M.
    Kaubisch, A.
    Goel, S.
    Mani, S.
    Ghalib, M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors
    Sunil Sharma
    Joachim Beck
    Monica Mita
    Sofia Paul
    Margaret M. Woo
    Margaret Squier
    Brian Gadbaw
    H. Miles Prince
    Investigational New Drugs, 2013, 31 : 974 - 985
  • [46] Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors
    Macaulay, Valentine M.
    Middleton, Mark R.
    Eckhardt, S. Gail
    Rudin, Charles M.
    Juergens, Rosalyn A.
    Gedrich, Richard
    Gogov, Sven
    McCarthy, Sean
    Poondru, Srinivasu
    Stephens, Andrew W.
    Gadgeel, Shirish M.
    CLINICAL CANCER RESEARCH, 2016, 22 (12) : 2897 - 2907
  • [47] Phase I dose-escalation study of E7080, a multikinase inhibitor, in patients with advanced solid tumors
    Nemunaitis, J. J.
    Senzer, N. N.
    Kurzrock, R.
    Ng, C. S.
    Das, A.
    Atienza, R. S.
    Zang, E. A.
    Jansen, M.
    Ashworth, S.
    Hong, D. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] A phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumors
    Tracy Murray Stewart
    Apurva A. Desai
    Michael L. Fitzgerald
    Laurence J. Marton
    Robert A. Casero
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 1089 - 1096
  • [49] Phase I Dose-Escalation Study of VB-111, an Antiangiogenic Virotherapy, in Patients with Advanced Solid Tumors
    Brenner, Andrew J.
    Cohen, Yael C.
    Breitbart, Eyal
    Bangio, Livnat
    Sarantopoulos, John
    Giles, Francis J.
    Borden, Ernest C.
    Harats, Dror
    Triozzi, Pierre L.
    CLINICAL CANCER RESEARCH, 2013, 19 (14) : 3996 - 4007
  • [50] A phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumors
    Stewart, Tracy Murray
    Desai, Apurva A.
    Fitzgerald, Michael L.
    Marton, Laurence J.
    Casero, Robert A., Jr.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (06) : 1089 - 1096
12345